Copyright © Inderes 2011 - present. All rights reserved.
  • Latest
  • Markets
    • Morning Review
    • Stock Comparison
    • Financial Calendar
    • Dividends Calendar
    • Research
    • Articles
    • Transcripts
    • AGM Invitations
    • IPOs
  • inderesTV
  • Portfolio
  • Forum
  • Discovery
  • Q&A
  • About Us
    • Our Coverage
    • Team
Press release

SLG Kalmar AB wins urology tender including CoreTherm® treatments in Region Kalmar County

ProstaLund

SLG Kalmar AB won a urology tender in Region Kalmar County including CoreTherm® treatments (TUMT).

SLG changed hands on January 1 this year, which meant that the care agreements that previous owners had with Region Kalmar County ended and the new owner did not receive a corresponding agreement, which had a major impact on the number of CoreTherm® treatments during the first half of 2022. ProstaLund estimates that just over 100 fewer treatments were performed during the first half of 2022 at SLG compared to the same period in 2021.

Region Kalmar County announced a tender of urological care to the region at the beginning of June this year. The tender aimed to offer patients specialist medical expertise in urology located centrally in Kalmar County with a contract period of 4 years. TUMT competence was seen as particular added value in the tender evaluation. TUMT stands for transurethral microwave therapy and is the basis of ProstaLund's further developed thermotherapy treatment, CoreTherm® Concept. SLG Kalmar AB won the tender and has signed a 4-year contract with Region Kalmar County.

"It is very gratifying that SLG Kalmar won the tender and has now received an agreement with the region that enables a long-term approach in the work where they can develop the CoreTherm® business. The indications we have received from SLG mean that we believe that there are very good conditions for a return to previous production levels. It is also very gratifying for all gentlemen with benign prostatic hyperplasia in southern Sweden that there is again a clinic in reasonable proximity where those who so wish can get a CoreTherm® treatment without long waiting times.", says CEO Johan Wennerholm in a comment.

For further information, please contact:


Johan Wennerholm,  CEO
Tel. +46 (0) 730 429997
Email: johan.wennerholm@prostalund.com

About ProstaLund


ProstaLund AB is a Swedish medical technology company and a leading developer and manufacturer of innovative urological devices and treatments. The company’s lead product, CoreTherm, is a patented Thermotherapy treatment method for Benign Prostatic Hyperplasia (BPH) which can be tailored to suit the needs of each individual patient. CoreTherm is used today in hospitals and clinics in Sweden and worldwide. ProstaLund is listed on the Nasdaq First North Growth Market.

Certified Adviser:
Västra Hamnen Corporate Finance AB
Phone: +46 40 200 250
E-mail: ca@vhcorp.se

Attachments


SLG Kalmar AB wins urology tender including CoreTherm® treatments in Region Kalmar County

Find us on social media
  • Inderes Forum
  • Youtube
  • Instagram
  • Facebook
  • X (Twitter)
Get in touch
  • info@inderes.se
  • +46 8 411 43 80
  • Vattugatan 17, 5tr
    111 52 Stockholm
Inderes
  • About us
  • Our team
  • Careers
  • Inderes as an investment
  • Services for listed companies
Our platform
  • FAQ
  • Terms of service
  • Privacy policy
  • Disclaimer
Inderes’ Disclaimer can be found here. Detailed information about each share actively monitored by Inderes is available on the company-specific pages on Inderes’ website. © Inderes Oyj. All rights reserved.